AstraZeneca COVID-19 shot candidate shows promise among elderly in trials
The data, reported in part last month but published in full in The
Lancet medical journal on Thursday, suggest that those aged over 70 -
who are at higher risk of serious illness and death from COVID-19 -
could build robust immunity to the pandemic disease, researchers said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-covid-19-shot-candidate-shows-promise-among-elderly-in-trials/articleshow/79299148.cms
Lancet medical journal on Thursday, suggest that those aged over 70 -
who are at higher risk of serious illness and death from COVID-19 -
could build robust immunity to the pandemic disease, researchers said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-covid-19-shot-candidate-shows-promise-among-elderly-in-trials/articleshow/79299148.cms
Comments
Post a Comment